Schonfeld Strategic Advisors LLC Profound Medical Corp. Transaction History

Schonfeld Strategic Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$7.85 - $11.18 $2,355 - $3,354	300 Added 2.75%	11,200 $95,000
Q3 2023 Nov 14, 2023	BUY	$7.91 - $13.27 $2,373 - $3,981	300 Added 2.83%	10,900 $111,000
Q2 2023 Aug 14, 2023	SELL	$9.27 - $14.88 $927 - $1,488	-100 Reduced 0.93%	10,600 $137,000
Q1 2023 May 15, 2023	SELL	$8.85 - $13.27 $885 - $1,327	-100 Reduced 0.93%	10,700 $99,000
Q4 2022 Feb 14, 2023	SELL	$3.18 - $10.91 $954 - $3,273	-300 Reduced 2.7%	10,800 $117,000
Q3 2022 Nov 14, 2022	SELL	$3.99 - $9.3 $399 - $930	-100 Reduced 0.89%	11,100 $44,000
Q2 2022 Aug 15, 2022	SELL	$6.34 - $9.53 $634 - $952	-100 Reduced 0.88%	11,200 $81,000
Q1 2022 May 16, 2022	SELL	$8.16 - $11.33 $4,896 - $6,798	-600 Reduced 5.04%	11,300 $102,000
Q4 2021 Feb 14, 2022	SELL	$10.38 - $15.2 $1,038 - $1,520	-100 Reduced 0.83%	11,900 $134,000
Q3 2021 Nov 16, 2021	SELL	$13.6 - $17.88 $2,720 - $3,576	-200 Reduced 1.64%	12,000 $176,000
Q2 2021 Aug 16, 2021	SELL	$16.0 - $20.59 $3,200 - $4,118	-200 Reduced 1.61%	12,200 $199,000
Q1 2021 May 17, 2021	BUY	$19.16 - $28.09 $237,584 - $348,316	12,400 New	12,400 $250,000

8.93M

1.2K

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $146M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.